Discovery and preclinical characterization of BMS-986299, a first-in-class NLRP3 agonist with potent antitumor activity in combination with checkpoint blockade

Ashvinikumar Gavai

Frederic Reu

Ragini Vuppugalla

Ramola Sane

Anwar Murtaza

James Loy

Huilin Qi

Jie Fang

Adam Bata

John Thomas Hunt

james Burke

Miguel Sanjuan

Michael Wichroski

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com